Microbot Medical (MBOT) Stock Climbs On Robotic System Achievement

Microbot Medical MBOT Stock News

Microbot Medical Inc (NASDAQ: MBOT) is running for the top in the market this morning, and for good reason. The company said that a feasibility study surrounding the world’s first fully disposable surgical robotic system ended in positive results. Here’s what’s going on:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

MBOT Stock Heads Up On Positive Results

In the press release, Microbot Medical said that it has successfully concluded its feasibility animal study surrounding its LIBERTY Robotic System. As mentioned above, this is the world’s first fully disposable surgical robotic system.

In the release, MBOT said that the study met all of its endpoints with no intraoperative or adverse events. As a result, the study further supports the company’s objectives to allow physicians to conduct a catheter-based procedure from outside the catheterization laboratory. Ultimately, this tech will help to reduce radiation exposure, physical strain, and other cross contamination risk.

In the release, the company said that the feasibility study was performed by two leading physicians in the neuro vascular and peripheral vascular intervention spaces. The results from the study showed that the robotic system came with robust navigation capabilities, intuitive usability and accurate deployment of embolic agents.

In a statement, Harel Gadot, President, CEO, and Chairman at MBOT, had the following to offer:

We continue to validate the LIBERTY™ Robotic System and confirm our assertion that it has the potential to revolutionize the robotic surgery space by democratizing endoluminal procedures with enhanced clinical and economical outcomes. The freedom from capital equipment, coupled with the ability to operate LIBERTY™ remotely, especially in today’s COVID-19 healthcare environment, will potentially reduce the cross contamination between the surgical staff and patients on top of reducing radiation exposure. Overall, we believe that we are in the right market, at the right time and with the right solution.

This News Is Huge

The news released by Microbot Medical proved to be overwhelmingly positive. The company first unveiled its LIBERTY Robotic System in January of this year. Just a few short months later, and the feasibility study has completed, ending in positive results.

With this new system, physicians may soon have the ability to provide the medical services that keep their patients alive and happy, while avoiding risk associated with prolonged exposure to radiation and physical strain.

All in all, this could be a big revenue driver ahead, and the feasibility study proved that the company is headed in the right direction with this tech, making MBOT stock one to watch closely.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Don’t Miss The Next Big Story

Join our free mailing list below to receive real-time news alerts!

Subscribe Today!

* indicates required

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.